Vytrus Biotech. 

0
39
+$0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

20.24%Profit Margin
Profitable
2021
2022
2023
2024
5.31MRevenue
1.08MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VYTRF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Vytrus Biotech, S.A. develops, produces, and sells active ingredients from plant stem cells in Spain and internationally. It offers Clarivine that activates skin's regeneration processes; Quora Noni biomics for rejuvenating the skin microbiota; Deobiome Noni, a prebiotic deodorant to reduce the generation of body odour; Sarcoslim Re-Shape, an active ingredient to reduce fat on tissue; Capilia Longa that improves density in hair, eyebrows, and eyelashes; and Luminia Granatum that brightens skin, whitens dark spots, evens skin tone, and protects against oxidative stress. The company also provides Baolift that improves muscle tone and facial complexion; Elaya Renova that boosts hair tensegrity; Kannabia Sense, a prebiotic treatment that stimulates the skin microbiota to produce an in-situ postbiotic cocktail; Quora Noni to avoid the attack of skin harmful bacteria; Centella Reversa for facial complexion improvement; and Arabian Cotton to protect and repair cell structures against sun damage. In addition, it offers Photobiome, a prebiotic active that fights the skin photoageing process; Nectaria Lithops, an active ingredient that biophysically optimizes the skin microenvironment and vitamin D levels; Olea Vitae, a cellular oil against ageing; Turmeria Zen for skin hydration and wrinkles on stressed profiles; and Sensia Carota, a plant-based active that protects and prevents from the damage on sensitive and sensitized skins. Further, the company provides technology solutions, such as plasma rich in cell factors; phyto-peptidic, phyto-lipidic, and phyto-glucidic fractions; and phyto-cell fusions, as well as Vytrus TV to create an audiovisual space with added value for cosmetic formulation. It exports its products. Vytrus Biotech, S.A. was incorporated in 2009 and is headquartered in Barcelona, Spain.
Show more...
CEO
Employees
44
Country
Spain
ISIN
ES0105618005
WKN
000A3DHK4

Listings

0 Comments

Share your thoughts

FAQ

What is Vytrus Biotech. stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Grey Market exchange Vytrus Biotech. stocks are traded under the ticker VYTRF.
What is Vytrus Biotech. revenue for the last year?
Vytrus Biotech. revenue for the last year amounts to 5.31M USD.
What is Vytrus Biotech. net income for the last year?
VYTRF net income for the last year is 1.08M USD.
How many employees does Vytrus Biotech. have?
As of September 04, 2026, the company has 44 employees.
In which sector is Vytrus Biotech. located?
Vytrus Biotech. operates in the Other sector.
When did Vytrus Biotech. complete a stock split?
Vytrus Biotech. has not had any recent stock splits.